Literature DB >> 8954257

Structure and function of human IgA Fc receptors (Fc alpha R).

H C Morton1, M van Egmond, J G van de Winkel.   

Abstract

Receptors for the Fc region of IgA are expressed by many human cell types, especially phagocytes located in mucosal areas, where IgA is the prevalent antibody isotype. Binding of IgA-opsonized particles (e.g., bacteria, viruses) to Fc alpha R may trigger a plethora of cell-mediated immune effector functions designed to rid the body of the foreign invader. The IgA receptor present on myeloid cells such as neutrophils, eosinophils, and monocytes (Fc alpha RI or CD89) is a transmembrane glycoprotein that binds both IgA isotypes with similar affinity. Genetic characterization showed Fc alpha RI to be a more distantly related member of the Ig receptor gene family. Recently, Fc alpha RI was found to associate with the FcR gamma-chain signaling molecule through a unique charge-based mechanism. Fc alpha RI is, thus, connected to the intracellular machinery via the ITAM signaling motifs located within the cytoplasmic tail of FcR gamma-chain. Evidence exists in support of receptors for IgA (distinct from Fc alpha RI) on human T and B cells. IgA Fc receptors may, therefore, play a role in both the induction and control of an efficient (mucosal) immune response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8954257

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  27 in total

1.  Function of immunoglobulin A in immunity.

Authors:  M A Kerr
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

2.  Neutrophil lactoferrin release induced by IgA immune complexes differed from that induced by cross-linking of fcalpha receptors (FcalphaR) with a monoclonal antibody, MIP8a.

Authors:  W Zhang; B Bi; R G Oldroyd; P J Lachmann
Journal:  Clin Exp Immunol       Date:  2000-07       Impact factor: 4.330

3.  Immunoglobulin A-mediated protection against Bordetella pertussis infection.

Authors:  S M Hellwig; A B van Spriel; J F Schellekens; F R Mooi; J G van de Winkel
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 4.  Whipple's disease: a macrophage disease.

Authors:  Benoît Desnues; Melanie Ihrig; Didier Raoult; Jean-Louis Mege
Journal:  Clin Vaccine Immunol       Date:  2006-02

Review 5.  IgA nephropathy: clearance kinetics of IgA-containing immune complexes.

Authors:  Ann Chen; Sung-Sen Yang; Tsai-Jung Lin; Shuk-Man Ka
Journal:  Semin Immunopathol       Date:  2018-09-14       Impact factor: 9.623

6.  Intestinal IgA: novel views on its function in the defence of the largest mucosal surface.

Authors:  J Mestecky; M W Russell; C O Elson
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

Review 7.  Immunoglobulin A: A next generation of therapeutic antibodies?

Authors:  Jantine E Bakema; Marjolein van Egmond
Journal:  MAbs       Date:  2011-07-01       Impact factor: 5.857

8.  Evidence for a differential expression of the FcepsilonRIgamma chain in dendritic cells of atopic and nonatopic donors.

Authors:  Natalija Novak; Carmen Tepel; Susanne Koch; Klaudia Brix; Thomas Bieber; Stefan Kraft
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

9.  CD89-mediated recruitment of macrophages via a bispecific antibody enhances anti-tumor efficacy.

Authors:  Bingyu Li; Lijun Xu; Chenyu Pi; Yanxin Yin; Kun Xie; Fei Tao; Renhao Li; Hua Gu; Jianmin Fang
Journal:  Oncoimmunology       Date:  2017-10-12       Impact factor: 8.110

10.  Human IgA-binding peptides selected from random peptide libraries: affinity maturation and application in IgA purification.

Authors:  Takaaki Hatanaka; Shinji Ohzono; Mirae Park; Kotaro Sakamoto; Shogo Tsukamoto; Ryohei Sugita; Hiroyuki Ishitobi; Toshiyuki Mori; Osamu Ito; Koichi Sorajo; Kazuhisa Sugimura; Sihyun Ham; Yuji Ito
Journal:  J Biol Chem       Date:  2012-10-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.